Safety, Acceptability and Preliminary Effectiveness of PC-515 for Vaginal Use as a Possible Microbicide

NCT00213031 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

165

Enrollment

OTHER

Sponsor class

Conditions

HIV Infections
Chlamydia Trachomatis
Neisseria Gonorrhoeae
Trichomonas Vaginitis
Syphilis
Herpes Simplex

Interventions

DRUG: Carraguard (PC-515)

Sponsor

Population Council

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]